U.S. Markets closed

  • S&P 500

    4,109.31
    +58.48 (+1.44%)
     

  • Dow 30

    33,274.15
    +415.12 (+1.26%)
     

  • Nasdaq

    12,221.91
    +208.43 (+1.74%)
     

  • Russell 2000

    1,802.48
    +34.10 (+1.93%)
     

  • Crude Oil

    75.70
    +1.33 (+1.79%)
     

  • Gold

    1,987.00
    -10.70 (-0.54%)
     

  • Silver

    24.24
    +0.25 (+1.03%)
     

  • EUR/USD

    1.0847
    -0.0062 (-0.5640%)
     

  • 10-Yr Bond

    3.4940
    -0.0570 (-1.61%)
     

  • Vix

    18.70
    -0.32 (-1.68%)
     

  • GBP/USD

    1.2332
    -0.0058 (-0.4686%)
     

  • USD/JPY

    132.7970
    +0.1080 (+0.0814%)
     

  • BTC-USD

    28,480.34
    -74.47 (-0.26%)
     

  • CMC Crypto 200

    621.79
    +7.58 (+1.23%)
     

  • FTSE 100

    7,631.74
    +11.31 (+0.15%)
     

  • Nikkei 225

    28,041.48
    +258.55 (+0.93%)
     

Global Markets for Catheters 2022: Increase in Minimally Invasive Procedures Increases Demand and Drives Growth

Research and Markets
·4 min read
Company Logo
Company Logo

Global Catheters Market

Global Catheters Market
Global Catheters Market

Dublin, Dec. 08, 2022 (GLOBE NEWSWIRE) -- The "Global Markets for Catheters" report has been added to ResearchAndMarkets.com's offering.

The global catheter market is a diverse industry with both multinational companies and smaller regional companies participating in a very competitive market. Segments of the market covered in this report include cardiovascular, urological, neurovascular, and intravenous catheters, as well as specialty products such as suction, thermodilution, oximetry catheters, anesthesia, and reproductive catheters. In some areas, particularly neurovascular, some procedures would not be possible without the use of catheters.

The number of catheterization procedures performed worldwide is affected by:

  • A globally aging population and its healthcare needs.

  • Higher incidences of chronic diseases, such as heart disease, stroke, cancer, diabetes, and obesity.

  • The effects of weak economies on overall healthcare utilization rates.

  • Efforts by third-party payers to lower costs associated with medical procedures.

  • Investigations by governmental agencies into potential overutilization of procedures.

  • The implementation by hospitals of policies designed to reduce the incidence of unnecessary procedures.

  • Growing concerns over infection rates with catheter use, which is improving technologies.

  • New diagnostic imaging and functional assessment modalities that more effectively screen patients to determine the need for treatment.

  • The market for catheters in medically advanced regions such as the U.S. and Western Europe is more mature, particularly for products in the urological and intravenous areas. Growth in developed regions will be mainly due to:

  • Introduction of advanced catheters during the forecast period.

  • An increase in the over-65 segment of the population.

  • The continued rise in chronic diseases such as heart disease.

The U.S. remains the most significant source of revenue for catheter manufacturers, but decreasing market share in the U.S., Europe and Japan will be absorbed by nations such as China, Russia, Eastern European countries, and Brazil.

Market growth will be driven by such factors as the growing incidence of obesity, diabetes and cardiovascular disease, all of which will contribute to the long-term growth in the number of interventional procedures.

Report Includes

  • 35 data tables and 34 additional tables

  • A detailed review and up-to-date analysis of the global markets for catheters

  • Analyses of the global market trends, with historic market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027

  • Highlights of the upcoming market potential for catheters, and areas of focus to forecast this market into various segments and sub-segments

  • Estimation of the actual market size and revenue forecast for global catheters market in USD million values, and corresponding market share analysis by product, application/disease type, and region

  • In-depth information (facts and figures) concerning the major market dynamics, technology updates, industry overviews, and competitive environment of the leading market participants

  • Review of the international regulatory landscape and the U.S. premarket notifications and approvals for catheters with emphasis on recently approved products as well as products under development or in different stages of clinical trials

  • Assessment of the recent U.S. patents and patent applications on the catheters market

  • Insight into recent industry structure, current competitive environment, ongoing research (R&D) activities, new product launches, strategic alliances, and company value share analysis based on their segmental revenues

Market Dynamics

Drivers

  • Increase in Minimally Invasive Procedures Increases Demand for Catheters

  • Increased Demand for Disposable Catheters

  • New Technologies in Catheter Design Increase Catheter Use

  • Advances in Imaging Technology Leads to New Applications Requiring the Use of Catheters

Restraints

  • Price Erosion Due to Fierce Competition Decreases Revenue Potential

  • Longer Approval Times Delay New Product Launches

  • Reimbursement Issues Affect the Use of Technology

  • Experienced Physicians are Often Reluctant to Accept New Device Technologies

Report Attribute

Details

No. of Pages

220

Forecast Period

2022 - 2027

Estimated Market Value (USD) in 2022

$30.8 Billion

Forecasted Market Value (USD) by 2027

$42.5 Billion

Compound Annual Growth Rate

6.6%

Regions Covered

Global


Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

Chapter 4 Market Dynamics

Chapter 5 Impact of COVID-19 Pandemic

Chapter 6 Global Market for Catheters by Application

Chapter 7 Global Market for Catheters by Region

Chapter 8 U.S. Patent Analysis

Chapter 9 U.S. Premarket Notifications and Approvals

Chapter 10 Market Opportunities

Chapter 11 Competitive Landscape

Chapter 12 Company Profiles

Chapter 13 Appendix: Acronyms

Companies Mentioned

  • Abbott Laboratories

  • Angiodynamics

  • Argon Medical Devices Inc.

  • B. Braun Melsungen Ag

  • Becton, Dickinson And Co.

  • Biosense Webster (Johnson & Johnson)

  • Boston Scientific Corp.

  • C.R. Bard

  • Cardinal Health

  • Cardiomed Supplies Inc.

  • Coloplast A/S

  • Cook Medical Inc.

  • Depuy Synthes

  • Edwards Lifesciences Corp.

  • Flexicath Ltd.

  • Goodman Co. Ltd.

  • Hollister Inc.

  • ICU Medical Inc.

  • Integra Lifesciences

  • Manfred Sauer Gmbh

  • Maquet Getinge Group

  • Medical Components Inc.

  • Medline Industries Inc.

  • Medtronic

  • Merit Medical Systems Inc.

  • Microport Scientific Corp.

  • Pulsion Medical Systems Se

  • Sanovas Inc.

  • Siemens Medical Solutions Usa, Inc.

  • Smiths Group Plc

  • Spectranetics

  • St. Jude Medical

  • Straub Medical Ag

  • Stryker

  • Teleflex Inc.

  • Terumo Corp.

  • Vascular Solutions Inc.

  • Volcano Corp.

For more information about this report visit https://www.researchandmarkets.com/r/6kl2bo

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Recommended Stories

  • How much you need to earn to afford a $500,000 home

    The average U.S. home sales price hit $535,800 in 2022. We asked experts how much you need to earn to afford a home around that price point.

  • Seeking at Least 8% Dividend Yield? Goldman Sachs Suggests 2 Dividend Stocks to Buy

    One thing is certain in the stock markets lately: their inherent uncertainty is taking charge, and high volatility is here to stay. For months, investors and economists have worried about the recessionary effects of the Federal Reserve’s anti-inflationary interest rate hikes – but the recent bank crisis has added another layer of concern to an already tumultuous situation. Now, we’re dealing with the fallout from that crisis, and inflation and interest rates both remain high. It’s a textbook cas

  • Schwab Hit by Worst Month Since 1987 Amid Cash Sorting Woes

    (Bloomberg) -- Charles Schwab Corp.’s worst month in more than 35 years has sparked a debate among analysts as to whether the brokerage giant has been unfairly punished by investors amid growing fears about the US banking sector.Most Read from BloombergTrump Weighs Bid to Shift NY Criminal Case to Staten IslandVeteran Money Managers Bail on Stock Rally With Fed Hawks FlyingParents Are Paying Consultants $750,000 to Get Kids Into Ivy League SchoolsGlobal Food Supply Risks Rise as Key Traders Leav

  • US Power Plant Firm Goes Bankrupt After Winter Storm Penalties

    (Bloomberg) -- Lincoln Power LLC, the owner of two Illinois power plants, filed for bankruptcy after its financial strain was exacerbated by nearly $39 million in penalties levied by the biggest US electric-grid operator. Most Read from BloombergTrump Weighs Bid to Shift NY Criminal Case to Staten IslandVeteran Money Managers Bail on Stock Rally With Fed Hawks FlyingParents Are Paying Consultants $750,000 to Get Kids Into Ivy League SchoolsGlobal Food Supply Risks Rise as Key Traders Leave Russi

  • JPMorgan's Bob Michele Issues Dire Warning On Rally Of Risk Assets, Says Recession Is Inevitable

    Bob Michele, the chief investment officer of JPMorgan Asset Management, has warned of an economic downturn, saying that markets are headed for a rally before an inevitable slowdown. In an interview with Bloomberg on Friday, Michele says risk assets will rise in the next quarter as they did during the Great Recession. "In the next quarter, we could see risk assets rally. You could have a feel-good period, and then the reality catches up," Michele said. "If we've been taught anything this month, y

  • A $200,000 Annuity Will Pay Out This Much a Month

    An annuity can be an appealing option to build your retirement nest egg. Adding guaranteed retirement income to your retirement can give you financial stability. But the exact amount that you'll get from an annuity each month will vary. Let's … Continue reading → The post How Much Does a $200,000 Annuity Pay Per Month? appeared first on SmartAsset Blog.

  • The next market trend could be 'bigger' than SVB, expert says

    Even though the Federal Reserve might have started bending the inflation curve, Mick Mulvaney and Anton Schutz warn the central bank is ignoring "the real problem out there."

  • Biden Administration to Move Forward With Changes to Medicare Payments

    The Biden administration will move ahead with changes that could reduce federal payments to many private Medicare plans, but will phase them in more slowly than it had planned under an earlier proposal that drew huge pushback from the industry. The final payment policy for the private Medicare plans, known as Medicare Advantage, was released Friday and will take effect next year. Medicare officials said the changes are aimed at making sure payments are accurate, and that they chose to phase them in more gradually after getting feedback from the industry and others.

  • 7 Dividend Stocks for Uncertain Economic Times

    Treasuries aren't the only refuge in a slowdown. Dividend names also "can provide a margin of safety," says UBS.

  • Procrastinators, Rejoice: The 6.89% I bonds Will Beat the Old 9.62% Bonds in Just 4 Years

    With a yield of 9.62%, the recently expired Series I bond was understandably popular. With interest rates rising, bond funds are down this year and banks continue to offer miserly rates on deposit accounts. So it's no wonder that a … Continue reading → The post It Pays to Procrastinate: The New 6.89% I bonds Will Beat the Old 9.62% Bonds in Just 4 Years appeared first on SmartAsset Blog.

  • The 10 best 1-year CD rates for April 2023

    Check out the CDs that made our top 10 list based on their APY, minimum opening deposit, compounding frequency, and customer service.

  • The Newest ‘Bubble’ Is in Money-Market Funds

    People are rushing into money-market funds. Total assets held in money-market funds, which are investment vehicles that buy cash-like securities such as short-term Treasury bills, recently reached close to $5.5 trillion, according to RBC. Earlier this year, money-market fund assets stood at roughly $4.5 trillion, a level at which people stopped pouring more money into those funds a few times in the past few years, opting instead to buy other assets like stocks.

  • Republic First Is ‘NOT’ First Republic, But Try Telling Traders That

    (Bloomberg) -- A case of mistaken identity is sparking a selloff in Republic First Bancorp Inc., which had fallen by more than 40% this month because investors have it confused with embattled First Republic Bank.Most Read from BloombergTrump Weighs Bid to Shift NY Criminal Case to Staten IslandVeteran Money Managers Bail on Stock Rally With Fed Hawks FlyingParents Are Paying Consultants $750,000 to Get Kids Into Ivy League SchoolsGlobal Food Supply Risks Rise as Key Traders Leave RussiaPutin Sig

  • Dow Jones Rises 150 Points After Cool Inflation Data; 6 Stocks To Buy And Watch

    The Dow Jones rose Friday after key inflation data, with the release of the PCE price index, the Fed's preferred measure of inflation.

  • Baby Boomers, You Need This Much Money to Retire Comfortably

    The Baby Boomer generation is reaching retirement age in record numbers. With more Boomers retiring on a daily basis, it helps to understand how prepared they are to leave their jobs for good. In this article, we’ll discuss the average … Continue reading → The post Average Retirement Savings for Baby Boomers appeared first on SmartAsset Blog.

  • Can I Actually Retire at 30 With $10 Million?

    The sum of $10 million might sound like a lot – and to the average person, it is. But what if you want to retire at just 30 years old and potentially live another 40, 50 or even 60 years … Continue reading → The post Is $10 million Enough to Retire at 30? appeared first on SmartAsset Blog.

  • The Charles Schwab Corporation (SCHW) Stock Sinks As Market Gains: What You Should Know

    The Charles Schwab Corporation (SCHW) closed the most recent trading day at $52.38, moving -0.17% from the previous trading session.

  • ‘Everyone is kind of tired and has given up’ on COVID. But this new variant is ‘one to watch,’ the WHO says

    Here’s what we know so far about the latest variant to raise eyebrows—and the first to do so in several months.

  • Virgin Orbit’s sudden collapse is the latest in a series of high-risk failures by Richard Branson

    The satellite deployment startup founded by Branson is letting go of the bulk of its staff, citing an “inability to secure meaningful funding.”

  • Market Rally Builds Momentum; Tesla Breaks Out With Deliveries Due

    The market rally is building momentum with more stocks flashing buy signals. Tesla deliveries are due as EV rivals report Q1 sales.